The Europe Bioabsorbable Stents Market would witness market growth of 6.6% CAGR during the forecast period (2021-2027). Stents are fixed in the artery with an aim to eliminate the blockades in the heart during the surgical procedure known as a percutaneous coronary intervention. Stents assists in opening the arteries and decreases the possibility of heart attacks. Conventionally, stents are developed from metal mesh and stay in the body permanently until they are taken out with the help of surgical intervention. However, these days, bioabsorbable stents are created with materials that easily get dissolved or absorbed in the body. There is no permanent implantation of a bioabsorbable stent. It gets slowly resorbed and harmlessly cleared from the body.
The European region is witnessing a rise in aging population, specifically those who are more vulnerable to heart-related diseases that require surgeries related to stents. This is a major driver for the demand & growth of bioabsorbable stents in the region. existence of many players in the European region who are constantly coming up with novel devices in the medical domain of coronary stents, would speed up the growth of the European bioabsorbable stents market.
However, people are getting more aware of the side effects that arise post-surgery of stents, which could hinder the further development of the market. On the other hand, physicians working in the regional market are constantly demanding better tools to treat highly complex cases, which involve multiple or completely blocked arteries and complications like diabetes. Responding to these demands, many players operating in the regional market are coming up with new products with the goal of assisting many people with coronary artery disease to regain their health and return to their daily lives as soon as possible.
The Germany market dominated the Europe Peripheral Artery Disease Market by Country in 2020, thereby, achieving a market value of $8.6 Million by 2027. The UK market is exhibiting a CAGR of 6.2% during (2021-2027). Additionally, The France market is anticipated to witness a CAGR of 8.5% during (2021-2027).
Based on Biomaterial, the market is segmented into Polymeric and Metallic. Based on Application, the market is segmented into Coronary Artery Disease and Peripheral Artery Disease. Based on End User, the market is segmented into Hospital and Cardiac Center. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Bioabsorbable Stents Market Size will Hit $429.2 Million by 2027, at a CAGR of 6.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, MicroPort Scientific Corporation, Terumo Corporation, Arterius Ltd., Elixir Medical Corporation, Amaranth Medical, Inc., and REVA Medical, LLC.
By Biomaterial
By Application
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
